Centre Co-Directors

professor_michael_hanna
Professor Michael Hanna

Centre Co-Director

professor_mary_reilly
Professor Mary Reilly

Centre Co-Director

Patient Services
patient and clinician

Patient Services

Access our patient information for muscle and nerve diseases.

Research
staff group

Research

Research from UCL, Newcastle University and the UCL Institute of Child Health.

Training and fellowships
people in a meeting

Training and fellowships

Find out about our studentships and fellowships.

About Us
QS CNMD logo

About Us

About the Centre, our team and how to contact us.

Conferences and Events
conference foyer

Conferences and Events

Events run by the Centre.

Partners and networks
neuron graphic

Partners and networks

Collaborators in research, clinical practice and patient support.

Fundraising and Donations

How to support our work

Donate

Contact

Box 102
National Hospital for Neurology and Neurosurgery
Queen Square
London WC1N 3BG

News

Dr Gita Ramdharry awarded £1.6m NIHR Fellowship
Dr Gita Ramdharry awarded £1.6m NIHR Fellowship

Dr Gita Ramdharry awarded £1.6m NIHR Fellowship

Congratulations to Dr Gita Ramdharry who has been awarded a £1.6 million NIHR Advanced Clinical and Practitioner Academic Fellowship

29 Aug 2025

Professor Reilly receives American Association of Neuromuscular & Electrodiagnostic Medicine award.
Professor Reilly receives American Association of Neuromuscular & Electrodiagnostic Medicine award.

Professor Reilly receives American Association of Neuromuscular & Electrodiagnostic Medicine award.

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) is proud to present the the 2025 Honorary Member Award Professor Mary Reilly (UCL Queen Square Institute of Neurology).

07 Aug 2025

£1million to help find new treatments for muscle wasting condition
£1million to help find new treatments for muscle wasting condition

£1million to help find new treatments for muscle wasting condition

Professor Mary Reilly receives £1 million funding from UK charity to help track progression in a group of rare conditions.

15 Jul 2025